Patents by Inventor Joan Connolly

Joan Connolly has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Improved Lyophilized Formulation
    Publication number: 20250057915
    Abstract: Provided herein are improved formulations of tagraxofusp for lyophilization used to manufacture stable formulations of tagraxofusp for intravenous injection.
    Type: Application
    Filed: November 4, 2024
    Publication date: February 20, 2025
    Applicant: Stemline Therapeutics, Inc.
    Inventors: Joan Connolly, Frederick Erickson, Madhav Kamat, Jennifer Wasserman, James Zabrecky
  • Lyophilized formulation
    Patent number: 12171800
    Abstract: Provided herein are improved formulations of tagraxofusp for lyophilization used to manufacture stable formulations of tagraxofusp for intravenous injection.
    Type: Grant
    Filed: June 8, 2023
    Date of Patent: December 24, 2024
    Assignee: Sterline Therapeutics, Inc.
    Inventors: Joan Connolly, Frederick Erickson, Madhav Kamat, Jennifer Wasserman, James Zabrecky
  • Lyophilized Formulation
    Publication number: 20230355709
    Abstract: Provided herein are improved formulations of tagraxofusp for lyophilization used to manufacture stable formulations of tagraxofusp for intravenous injection.
    Type: Application
    Filed: June 8, 2023
    Publication date: November 9, 2023
    Applicant: Stemline Therapeutics, Inc.
    Inventors: Joan Connolly, Frederick Erickson, Madhav Kamat, Jennifer Wasserman, James Zabrecky